Galderma Labs Seeks OK Of Award Over Botox-Like Treatment

By Joyce Hanson · January 3, 2024, 10:10 PM EST

Galderma Laboratories has asked a Texas federal court to enforce an arbitral award in its trade secrets dispute with Ipsen Biopharm over an application seeking U.S. government approval of a Botox-like...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief

Case Information

Case Title

Ipsen Biopharm Ltd et al v. Galderma Laboratories LP et al

Case Number

Court

Texas Northern

Nature of Suit

Other Statutes: Arbitration

Date Filed

November 22, 2023

Recent Articles By Joyce

May 10, 2024
Retail Group Opposes $1B Arbitral Award Against Walgreens
May 07, 2024
Swiss Co. Says $8M Equatorial Guinea Award Is Valid
May 06, 2024
Chickasaw Can't Reopen Optum Prescription Payback Suit
April 18, 2024
Pharma Co. Wants Tribe's Opioid Suit To Stay In Federal Court
April 09, 2024
Investor Can't Get Approval Of Hong Kong Award In Calif.
April 04, 2024
Tribes And McKinsey Take Final Step In $39.5M Opioid Deal
January 17, 2024
Caremark Wants Tribe's Prescription Claim Suit Arbitrated
January 16, 2024
IHS Wants Tribes' Input On $250M To Combat Fentanyl Crisis
December 01, 2023
Judge Chides Tribe Seeking Blue Cross Default As 'Obstinate'
November 30, 2023
Navajo-IHS Dispute Paused Pending Supreme Court Ruling